Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19)
Fig 12
Shows the pooled analysis of the duration of hospitalisation of oseltamivir monotherapy vs HCQ monotherapy.